Sage Mountain Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $382K | Sell |
5,536
-320
| -5% | -$22.1K | 0.02% | 283 |
|
|
2025
Q1 | $407K | Buy |
5,856
+97
| +2% | +$6.74K | 0.03% | 251 |
|
|
2024
Q4 | $495K | Sell |
5,759
-838
| -13% | -$72.1K | 0.04% | 213 |
|
|
2024
Q3 | $786K | Buy |
6,597
+391
| +6% | +$46.6K | 0.07% | 140 |
|
|
2024
Q2 | $886K | Buy |
6,206
+1,697
| +38% | +$242K | 0.08% | 107 |
|
|
2024
Q1 | $579K | Buy |
4,509
+341
| +8% | +$43.8K | 0.06% | 138 |
|
|
2023
Q4 | $431K | Buy |
4,168
+202
| +5% | +$20.9K | 0.05% | 148 |
|
|
2023
Q3 | $361K | Buy |
3,966
+542
| +16% | +$49.3K | 0.05% | 160 |
|
|
2023
Q2 | $277K | Sell |
3,424
-10
| -0.3% | -$809 | 0.04% | 196 |
|
|
2023
Q1 | $273K | Buy |
+3,434
| New | +$273K | 0.04% | 180 |
|